does tirzepatide cause hives Mounjaro Rash Side Effects (2026): Symptoms & Treatment Tirzepatide injection site reaction treatment:
Description
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors in metabolic research models
Download this stock image: Tirzepatide auto-injector: Medical device ready for use in the leg for chronic management
Major cardiovascular outcome trials and real-life observations have proven that glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), regardless of structural GLP-1 homology, exert clinically relevant cardiovascular protection
Tirzepatide's half-life is approximately 5 days, meaning the body clears roughly half the dose weekly
